United Kingdom· GB-APID-43908411000001108
Fruzaqla 5mg capsules
A fruquintinib product containing fruquintinib, registered in United Kingdom by Takeda UK Ltd. The same ATC class is registered in 16 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Fruquintinib is registered in 16 of 19 countries.
Countries holding a registration under ATC L01EK04 (fruquintinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Fruquintinib · ATC L01EK04
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fruquintinib costs, country by country.
Normalised to the WHO defined daily dose (3.75 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fruquintinib · price per daily dose (3.75 mg)
USD · FX 28 Sept 2026
- CH Switzerland$189.98
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Fruquintinib
- Manufacturer
- Takeda UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EK04
- ATC class
- Fruquintinib
- Defined daily dose
- 3.75 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin07038319163331
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fruquintinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFruzaqlaTakeda Pharmaceuticals America, Inc.
- CanadaFRUZAQLATAKEDA CANADA INC
- SwitzerlandFruzaqla
- CzechiaFRUZAQLATakeda Pharmaceuticals International AG Ireland Branch, Dublin
- SpainFRUZAQLA 5 MG CAPSULAS DURASTakeda Pharmaceuticals International Ag Ireland Branch
- FinlandFRUZAQLATakeda Pharmaceuticals International AG Ireland Branch
- FranceFRUZAQLA 5 mg, géluleTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- BelgiumFruzaqla 5 mgTakeda Pharmaceuticals International Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fruzaqla
- Liechtenstein · Fruzaqla
- Norway · Fruzaqla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4450c6f-5083-4006-9664-5023af2db0df GET /v1/drugs/f4450c6f-5083-4006-9664-5023af2db0df?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "43908411000001108",
"desc": "Fruzaqla 5mg capsules (Takeda UK Ltd)",
"form": "Oral capsule",
"vpid": "44027811000001107",
"source": "dmd",
"vtm_id": "44011811000001108",
"strength": "5 mg",
"substance": "Fruquintinib",
"ingredient": "Fruquintinib",
"supplier_code": "3811601000001107"
}See everything about fruquintinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.